K. Müller

Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions

J. Jansen, R. Burger, M. Peipp, 2021, Cancer Science.

Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL.

M. Schrappe, C. Eckert, A. Kulozik, 2022, Blood.

Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions

J. Jansen, R. Burger, M. Peipp, 2021, Cancer science.

Enhanced potency of immunotherapy against B‐cell precursor acute lymphoblastic leukemia by combination of an Fc‐engineered CD19 antibody and CD47 blockade

M. Peipp, T. Valerius, K. Müller, 2024, HemaSphere.